U.T. Seyfert

1.8k total citations
57 papers, 1.3k citations indexed

About

U.T. Seyfert is a scholar working on Hematology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, U.T. Seyfert has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 17 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in U.T. Seyfert's work include Blood transfusion and management (14 papers), Platelet Disorders and Treatments (13 papers) and Venous Thromboembolism Diagnosis and Management (12 papers). U.T. Seyfert is often cited by papers focused on Blood transfusion and management (14 papers), Platelet Disorders and Treatments (13 papers) and Venous Thromboembolism Diagnosis and Management (12 papers). U.T. Seyfert collaborates with scholars based in Germany, United States and Austria. U.T. Seyfert's co-authors include V. Biehl, Joachim Schenk, Peter Hellstern, F. Jung, Hannelore Haubelt, G. Pindur, Robert B. Francis, Birgit Theisinger, Markus Seifert and Cornelius Welter and has published in prestigious journals such as Journal of Biological Chemistry, Kidney International and The Annals of Thoracic Surgery.

In The Last Decade

U.T. Seyfert

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
U.T. Seyfert Germany	19	381	365	297	233	227	57	1.3k
Arthur P. Bode United States	21	620 1.6×	219 0.6×	101 0.3×	263 1.1×	209 0.9×	49	1.1k
Nina A. Guzzetta United States	21	344 0.9×	316 0.9×	236 0.8×	453 1.9×	199 0.9×	49	1.2k
Salzman Ew United States	27	597 1.6×	579 1.6×	517 1.7×	99 0.4×	445 2.0×	68	2.2k
V. Kretschmer Germany	17	525 1.4×	136 0.4×	164 0.6×	139 0.6×	99 0.4×	129	1.1k
Sven R. Olson United States	18	378 1.0×	211 0.6×	243 0.8×	61 0.3×	124 0.5×	52	1.2k
Anders Bylock Sweden	20	231 0.6×	480 1.3×	745 2.5×	88 0.4×	145 0.6×	50	1.6k
Piet Jansen Netherlands	22	214 0.6×	1.2k 3.3×	976 3.3×	111 0.5×	166 0.7×	47	2.2k
Nathan J. White United States	21	477 1.3×	345 0.9×	52 0.2×	654 2.8×	249 1.1×	73	1.6k
D.P. Dhall United Kingdom	22	278 0.7×	237 0.6×	202 0.7×	75 0.3×	401 1.8×	49	965
Edward Young Canada	22	470 1.2×	819 2.2×	723 2.4×	71 0.3×	112 0.5×	37	2.2k

Countries citing papers authored by U.T. Seyfert

Since Specialization

Citations

This map shows the geographic impact of U.T. Seyfert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U.T. Seyfert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U.T. Seyfert more than expected).

Fields of papers citing papers by U.T. Seyfert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U.T. Seyfert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U.T. Seyfert. The network helps show where U.T. Seyfert may publish in the future.

Co-authorship network of co-authors of U.T. Seyfert

This figure shows the co-authorship network connecting the top 25 collaborators of U.T. Seyfert. A scholar is included among the top collaborators of U.T. Seyfert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U.T. Seyfert. U.T. Seyfert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geisthoff, Urban W., et al.. (2014). Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study. Thrombosis Research. 134(3). 565–571. 74 indexed citations

Fritsch, Esther, et al.. (2008). Verzögerte hämolytische Transfusionsreaktion durch irreguläre Antikörper der Spezifität Anti-Kidd(a). DMW - Deutsche Medizinische Wochenschrift. 122(43). 1313–1316.

Hauck, Walter W. & U.T. Seyfert. (2008). Die Ultraschalluntersuchung der Neugeborenenhüfte. Zeitschrift für Orthopädie und ihre Grenzgebiete. 128(6). 570–574. 1 indexed citations

Kleinschmidt, S., et al.. (2003). St�rungen der H�mostase bei Patienten in der HNO-Heilkunde. HNO. 51(2). 168–181. 3 indexed citations

Nickels, Ruth M., U.T. Seyfert, E. Wenzel, Michael D. Menger, & Brigitte Vollmar. (2003). A simple and reproducible method to reliably assess platelet activation. Thrombosis Research. 110(1). 53–56. 1 indexed citations

Plinkert, P. K., et al.. (2003). St�rungen der H�mostase bei Patienten in der HNO-Heilkunde. HNO. 51(3). 251–266. 3 indexed citations

Seyfert, U.T., V. Biehl, & Joachim Schenk. (2002). In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. Biomolecular Engineering. 19(2-6). 91–96. 161 indexed citations

Biehl, V., et al.. (2002). Evaluation of the haemocompatibility of titanium based biomaterials. Biomolecular Engineering. 19(2-6). 97–101. 42 indexed citations

Kleinschmidt, S., et al.. (2002). Die perioperative Therapie des Von-Willebrand-Syndroms. Der Anaesthesist. 51(10). 825–834. 2 indexed citations

10.

Jung, F., et al.. (2001). Haemocompatibility of Endovascular Coronary Stents: Wiktor GX©. Hämokompatibilität von Koronarstents: Wiktor GX©. Biomedizinische Technik/Biomedical Engineering. 46(7-8). 200–206. 9 indexed citations

11.

Pindur, G., et al.. (2001). Qualität von Erythrozytenkonzentraten in Additivlösungen -Evaluierung mit Hilfe hämorheologischer Messmethoden. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 36(Suppl 1). 6–10. 1 indexed citations

12.

Duchow, J., Michael Ames, Thomas Heß, & U.T. Seyfert. (2001). Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty. The Journal of Arthroplasty. 16(7). 844–849. 21 indexed citations

13.

Risch, Anne Katrin, et al.. (2000). Auswirkung von Aprotinin und Tranexamsäure auf die Fibrinolyse und Thrombinbildung bei extrakorporaler Zirkulation. Der Anaesthesist. 49(4). 279–285. 12 indexed citations

14.

Kleinschmidt, S. & U.T. Seyfert. (1999). Die Heparin-induzierte Thrombozytopenie (HIT). Der Anaesthesist. 48(11). 771–785. 3 indexed citations

15.

Engel, Matthias, Markus Seifert, Birgit Theisinger, U.T. Seyfert, & Cornelius Welter. (1998). Glyceraldehyde-3-phosphate Dehydrogenase and Nm23-H1/Nucleoside Diphosphate Kinase A. Journal of Biological Chemistry. 273(32). 20058–20065. 112 indexed citations

16.

Mertzlufft, F., Anne Katrin Risch, & U.T. Seyfert. (1997). Der "TAS-Analyzer". Der Anaesthesist. 46(3). 233–235. 3 indexed citations

17.

Treib, J., G. Pindur, Markus T. Grauer, et al.. (1996). Influence of Low Molecular Weight Hydroxyethyl Starch (HES 40/0.5-0.55) on Hemostasis and Hemorheology. Pathophysiology of Haemostasis and Thrombosis. 26(5). 258–265. 18 indexed citations

18.

Kleinschmidt, S. & U.T. Seyfert. (1995). Heparin-Associated Thrombocytopenia (HAT)—Still a Diagnostic and Therapeutical Problem in Clinical Practice. Angiology. 46(1). 37–44. 15 indexed citations

19.

Feindt, P., U.T. Seyfert, I. Volkmer, U Straub, & E Gams. (1994). Celite and Kaolin Produce Differing Activated Clotting Times during Cardiopulmonary Bypass under Aprotinin Therapy. The Thoracic and Cardiovascular Surgeon. 42(4). 218–221. 18 indexed citations

20.

Feindt, P., U.T. Seyfert, I. Volkmer, et al.. (1994). Is there a phase of hypercoagulability when aprotinin is usedin cardiac surgery?. European Journal of Cardio-Thoracic Surgery. 8(6). 308–314. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact